Organisation paid for research Program year 2022 Source: CMS Open Payments

Hope Neurology PLLC

Neither a doctor nor a teaching hospital

Research payments

$3,439,031

10 payments

Through program year 2022, Hope Neurology PLLC is reported as receiving $3,439,031 in research payments, across 10 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$597,144	2
2021	Research	$1,695,058	4
2020	Research	$830,899	1
2019	Research	$315,931	3

Breakdown

Who paid Research payments · program years 2019–2022

Novartis Pharmaceuticals Corporation $3,439,031 10 payments

Studies the money was for Research payments · program years 2019–2022

An Open Label Single Arm Multi Center Extension Study Evaluating Long Term Safety Tolerability and Effectiveness of Ofatumumab in Subjects With Relapsing Multiple Sclerosis $2,240,003 3 payments
A Single-Arm, Prospective, Multi-Center Study to Explore Maintained Efficacy With Ofatumumab Therapy in Patients With Relapsing Multiple Sclerosis Who Discontinue Intravenously Delivered Anti-Cd20 Monoclonal Antibody (Acd20 Mab) Therapy (Olikos) $847,016 2 payments
A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 MG Subcutaneous Ofatumumab Injected By Pre-Filled Syringe Or Autoinjector in Adult RMS Patients $206,755 1 payment
An Open Label Study to Assess Response to Influenza Vaccine in Ofatumumab Treated Patients. $127,302 1 payment
Exploring the Safety and Tolerability of Conversion to Dose Titrated Siponimod in Patients With Relapsing Forms of Multiple Sclerosis A 6 Month Open Label Multi Center Phase III B Study Expanded $17,955 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.